tiprankstipranks
Trending News
More News >

Andrew Balo Insider Profile

4 Followers
Andrew Balo, EVP Regulatory Strategy Clinic at Dexcom, holds 81.12K shares in Dexcom (Ticker: DXCM).
tipranks
Andrew Balo

Andrew Balo
Dexcom (DXCM)
EVP Regulatory Strategy Clinic

Ranked #80,836 out of 100,956 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-43.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
100.00%
A breakdown of Andrew Balo's holdings

Insider Roles

Dexcom
(DXCM)
EVP Regulatory Strategy Clinic
Roles that Andrew Balo holds in companies

Most Profitable Insider Trade

Stock:
Dexcom
(DXCM)
Rating:Informative Sell
Date:Nov 24, 2015 - Nov 24, 2016
Return:+16.80%
The most profitable trade made by Andrew Balo

Andrew Balo's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Dexcom
Mar 14, 2023
EVP Regulatory Strategy Clinic
Uninformative Sell
1.30M
$6.31M
Success Rate for
DXCM
1 out of 2 profitable transactions on
DXCM
50%
Average Return for
DXCM
Average return per transaction on
DXCM
-43.55%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 10, 2011
Uninformative Buy
$0.00
-
$0.00
Mar 10, 2015
Uninformative Buy
$0.00
-
$0.00
Mar 11, 2014
Uninformative Buy
$0.00
-
$0.00
Mar 13, 2012
Uninformative Buy
$0.00
-
$0.00
Mar 13, 2013
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Andrew Balo's performance on stock

Andrew Balo insider profile FAQ

What is the percentage of profitable transactions made by Andrew Balo?
The percentage of profitable transactions made by Andrew Balo is 50%.
    What is the average return per transaction made by Andrew Balo?
    The average return per transaction made by Andrew Balo is -43.50%.
      What stocks does Andrew Balo hold?
      Andrew Balo holds: DXCM stocks.
        What was Andrew Balo’s latest transaction?
        Andrew Balo latest transaction was an Uninformative Sell of $1.30M.
          What was Andrew Balo's most profitable transaction?
          Andrew Balo’s most profitable transaction was an Informative Sell of DXCM stock on November 24, 2015. The return on the trade was 16.80%.
            What is Andrew Balo's role in Dexcom?
            Andrew Balo's role in Dexcom is EVP Regulatory Strategy Clinic.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.